Genelux GNLX
NASDAQ GNLX
$2.00 +0.02 (+1.01%)
At close: Oct 23, 2026 · 4:00 PM EDT

Genelux (GNLX) Other Accumulated Expenses (2024 - 2025)

Updated

Genelux's Other Accumulated Expenses was $455,000 in Q4 2025, up 138.2% from $191,000 a year earlier.

Analysis

Genelux (GNLX) Other Accumulated Expenses (2024 - 2025) Analysis & Trends

From Q4 2022 onward, Genelux has reported Other Accumulated Expenses for 5 quarters.

  • Other Accumulated Expenses shows a three-year compound annual growth rate of -27.2% (FY2022 to FY2025).
  • In earlier years, Other Accumulated Expenses was $191,000 in FY2024 (+855.0%), $20,000 in FY2023 (-98.3%) and $1.18 million in FY2022.
  • The Q4 2025 figure marks the highest quarterly Other Accumulated Expenses since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Genelux 87.86 Mn 26.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 455,000.00
Dec 31, 2024 191,000.00
API Access

Genelux Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GNLX&period=max&api_key=YOUR_API_KEY